Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
PMID 34304009
This homeostatic modulation, rather than directional stimulation, suggests a fundamentally different mechanism than most vasodilators
Following a single addition of 100 g/ml BPC 157, the vasorelaxation reached 37.6 5.7% (Fig
The two compounds in this category target complementary pathways of mitochondrial health: the NAD + activates sirtuins (SIRT1-7) and PARP-1 to restore energy metabolism and DNA repair, while the glutathione neutralizes reactive oxygen species generated by the mitochondrial respiratory chain
Preclinical studies show neuroprotective effects in models of traumatic brain injury, spinal cord compression, and peripheral nerve transection
The FDAs April 2026 action removed several peptides from the Section 503A Category 2 restricted list, and BPC-157 was among those with scheduled advisory committee review in July 2026
